Back to Search
Start Over
Other news from the FDA
- Source :
- Patient Care for the Nurse Practitioner. July 2003
- Publication Year :
- 2003
-
Abstract
- Levaquin (levofloxacin) has been approved by the FDA for the treatment of chronic bacterial prostatitis caused by Escherichia coli, Enterococcus faecalis, or Staphylococcus epidermidis. Counterfeit Lipitor (atorvastatin) continues to be [...]
- Subjects :
- Lipitor (Medication) -- Product defects and recalls
Levaquin (Medication) -- Licensing, certification and accreditation -- Product defects and recalls
Product defects and recalls
Licensing, certification and accreditation
Atorvastatin -- Product defects and recalls
Levofloxacin -- Licensing, certification and accreditation
Subjects
Details
- Language :
- English
- ISSN :
- 15264769
- Database :
- Gale General OneFile
- Journal :
- Patient Care for the Nurse Practitioner
- Publication Type :
- Periodical
- Accession number :
- edsgcl.138991370